Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China National Bluestar is a Chinese state-owned chemical and materials company focused on specialty chemicals, advanced materials, silicones, engineering plastics, and animal nutrition rather than biotechnology or pharmaceuticals. Founded in 1984 and later integrated into ChemChina, Bluestar expanded through domestic restructurings and international acquisitions, including assets such as Adisseo and Elkem. The company operates as part of the broader Sinochem/ChemChina state-owned industrial system and serves industrial and agricultural end markets globally. For a biotech analyst, the key point is that Bluestar is not a life sciences drug developer; its nearest healthcare adjacency is animal nutrition through Adisseo.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China National Bluestar.